From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Bismacine, also known as Chromacine, is a substance manufactured by American Biologics Corporation and marketed as a purported alternative treatment for Lyme disease. Bismacine contains high levels of bismuth, and two deaths are recorded following the use of intravenous bismacine to treat Lyme disease.[1] In 2006, the U.S. Food and Drug Administration warned consumers not to use bismacine, noting that it is ineffective and dangerous.[2]


  1. ^ Quirk M. (2006). "Alternative health therapy for Lyme disease results in death". Lancet Infect Dis. 6 (8): 546. doi:10.1016/S1473-3099(06)70563-1. 
  2. ^ "FDA Warns Consumers and Health Care Providers Not to Use Bismacine, also known as Chromacine". U.S. Food and Drug Administration. 2006-06-21. Retrieved 2008-10-16.